LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

PHASE3CompletedINTERVENTIONAL
Enrollment

1,154

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2016

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Investigator´s choice of chemotherapy

BIBW 2992 in a medium dose in combination with Paclitaxel to explore safety and efficacy versus investigator´s choice of chemotherapy

DRUG

BIBW 2992

BIBW 2992 will be given in a medium dose in combination with Paclitaxel to explore safety and efficacy versus investigator´s choice of chemotherapy

Trial Locations (97)

Unknown

Boehringer Ingelheim Investigational Site, Buenos Aires

Boehringer Ingelheim Investigational Site, Kingswood

Boehringer Ingelheim Investigational Site, South Brisbane

Boehringer Ingelheim Investigational Site, Box Hill

Boehringer Ingelheim Investigational Site, Fitzroy

Boehringer Ingelheim Investigational Site, Wodonga

Boehringer Ingelheim Investigational Site, Salzburg

Boehringer Ingelheim Investigational Site, Aalst

Boehringer Ingelheim Investigational Site, Brussels

Boehringer Ingelheim Investigational Site, Duffel

Boehringer Ingelheim Investigational Site, La Louvière

Boehringer Ingelheim Investigational Site, Liège

Boehringer Ingelheim Investigational Site, Middelheim

Boehringer Ingelheim Investigational Site, Ottignies

Boehringer Ingelheim Investigational Site, Porto Alegre

Boehringer Ingelheim Investigational Site, Beijing

Boehringer Ingelheim Investigational Site, Changchun

Boehringer Ingelheim Investigational Site, Chengdu

Boehringer Ingelheim Investigational Site, Fuzhou

Boehringer Ingelheim Investigational Site, Guangzhou

Boehringer Ingelheim Investigational Site, Hangzhou

Boehringer Ingelheim Investigational Site, Nanjing

Boehringer Ingelheim Investigational Site, Shanghai

Boehringer Ingelheim Investigational Site, Helsinki

Boehringer Ingelheim Investigational Site, Bayonne

Boehringer Ingelheim Investigational Site, Caen

Boehringer Ingelheim Investigational Site, Dijon

Boehringer Ingelheim Investigational Site, La Tronche

Boehringer Ingelheim Investigational Site, Lyon

Boehringer Ingelheim Investigational Site, Paris

Boehringer Ingelheim Investigational Site, Saint-Herblain

Boehringer Ingelheim Investigational Site, Villejuif

Boehringer Ingelheim Investigational Site, Berlin

Boehringer Ingelheim Investigational Site, Essen

Boehringer Ingelheim Investigational Site, Esslingen am Neckar

Boehringer Ingelheim Investigational Site, Gauting

Boehringer Ingelheim Investigational Site, Hamburg

Boehringer Ingelheim Investigational Site, Hanover

Boehringer Ingelheim Investigational Site, Heidelberg

Boehringer Ingelheim Investigational Site, Mainz

Boehringer Ingelheim Investigational Site, Münster

Boehringer Ingelheim Investigational Site, Budapest

Boehringer Ingelheim Investigational Site, Pécs

Boehringer Ingelheim Investigational Site, Törökbálint

Boehringer Ingelheim Investigational Site, Chennai

Boehringer Ingelheim Investigational Site, Jaipur

Boehringer Ingelheim Investigational Site, Maharashtra

Boehringer Ingelheim Investigational Site, Mumbai

Boehringer Ingelheim Investigational Site, Nashik, Maharashtra

Boehringer Ingelheim Investigational Site, Kfar Saba

Boehringer Ingelheim Investigational Site, Petah Tikva

Boehringer Ingelheim Investigational Site, Tel Litwinsky

Boehringer Ingelheim Investigational Site, Avellino

Boehringer Ingelheim Investigational Site, Aviano (PN)

Boehringer Ingelheim Investigational Site, Bergamo

Boehringer Ingelheim Investigational Site, Genova

Boehringer Ingelheim Investigational Site, Milan

Boehringer Ingelheim Investigational Site, Monza (mi)

Boehringer Ingelheim Investigational Site, Ravenna

Boehringer Ingelheim Investigational Site, Roma

Boehringer Ingelheim Investigational Site, Distrito Federal

Boehringer Ingelheim Investigational Site, Maastricht

Boehringer Ingelheim Investigational Site, Nieuwegein

Boehringer Ingelheim Investigational Site, Arequipa

Boehringer Ingelheim Investigational Site, La Victoria

Boehringer Ingelheim Investigational Site, Gdansk

Boehringer Ingelheim Investigational Site, Olsztyn

Boehringer Ingelheim Investigational Site, Otwock

Boehringer Ingelheim Investigational Site, Warsaw

Boehringer Ingelheim Investigational Site, Obninsk

Boehringer Ingelheim Investigational Site, Saint Petersburg

Boehringer Ingelheim Investigational Site, Goyang

Boehringer Ingelheim Investigational Site, Hwasun

Boehringer Ingelheim Investigational Site, Seoul

Boehringer Ingelheim Investigational Site, A Coruña

Boehringer Ingelheim Investigational Site, Barcelona

Boehringer Ingelheim Investigational Site, Madrid

Boehringer Ingelheim Investigational Site, Mataró

Boehringer Ingelheim Investigational Site, Málaga

Boehringer Ingelheim Investigational Site, Valencia

Boehringer Ingelheim Investigational Site, Kaohsiung City

Boehringer Ingelheim Investigational Site, Taichung

Boehringer Ingelheim Investigational Site, Tainan City

Boehringer Ingelheim Investigational Site, Taipei

Boehringer Ingelheim Investigational Site, Taoyuan District

Boehringer Ingelheim Investigational Site, Dnipropetrovks

Boehringer Ingelheim Investigational Site, Donetsk

Boehringer Ingelheim Investigational Site, Kharkiv

Boehringer Ingelheim Investigational Site, Kyiv

Boehringer Ingelheim Investigational Site, Brighton

Boehringer Ingelheim Investigational Site, Dundee

Boehringer Ingelheim Investigational Site, Exeter

Boehringer Ingelheim Investigational Site, London

Boehringer Ingelheim Investigational Site, Maidstone

Boehringer Ingelheim Investigational Site, Manchester

Boehringer Ingelheim Investigational Site, Sutton, Surrey

Boehringer Ingelheim Investigational Site, Truro, Cornwall

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY